Search: WFRF:(Wessels Lodewyk)
> (2018) >
A System-wide Appro...
A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer Cells
-
- Ressa, Anna (author)
- Univ Utrecht, Utrecht Inst Pharmaceut Sci, Biomol Mass Spectrometry & Prote Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands.
-
- Bosdriesz, Evert (author)
- Netherlands Canc Inst, Oncode Inst, Canc Genom Ctr Netherlands, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.
-
- de Ligt, Joep (author)
- Univ Utrecht, Univ Med Ctr Utrecht, Div Biomed Genet, Ctr Mol Med & Canc Genom Netherlands, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.
-
show more...
-
- Mainardi, Sara (author)
- Netherlands Canc Inst, Oncode Inst, Canc Genom Ctr Netherlands, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.
-
- Maddalo, Gianluca (author)
- KTH,Skolan för kemi, bioteknologi och hälsa (CBH),Science for Life Laboratory, SciLifeLab
-
- Prahallad, Anirudh (author)
- Netherlands Canc Inst, Oncode Inst, Canc Genom Ctr Netherlands, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.;Novartis Pharma AG, Novartis Inst BioMed Res, CH-4002 Basel, Switzerland.
-
- Jager, Myrthe (author)
- Univ Utrecht, Univ Med Ctr Utrecht, Div Biomed Genet, Ctr Mol Med & Canc Genom Netherlands, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.
-
- de la Fonteijne, Lisanne (author)
- Univ Utrecht, Univ Med Ctr Utrecht, Div Biomed Genet, Ctr Mol Med & Canc Genom Netherlands, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.
-
- Fitzpatrick, Martin (author)
- Univ Utrecht, Utrecht Inst Pharmaceut Sci, Biomol Mass Spectrometry & Prote Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands.
-
- Groten, Stijn (author)
- Univ Utrecht, Utrecht Inst Pharmaceut Sci, Biomol Mass Spectrometry & Prote Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands.
-
- Altelaar, A. F. Maarten (author)
- Univ Utrecht, Utrecht Inst Pharmaceut Sci, Biomol Mass Spectrometry & Prote Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands.
-
- Bernards, Rene (author)
- Netherlands Canc Inst, Oncode Inst, Canc Genom Ctr Netherlands, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.
-
- Cuppen, Edwin (author)
- Univ Utrecht, Univ Med Ctr Utrecht, Div Biomed Genet, Ctr Mol Med & Canc Genom Netherlands, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.
-
- Wessels, Lodewyk (author)
- Netherlands Canc Inst, Oncode Inst, Canc Genom Ctr Netherlands, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.;Delft Univ Technol, Dept EEMCS, Mekelweg 4, NL-2628 CD Delft, Netherlands.
-
- Heck, Albert J. R. (author)
- Univ Utrecht, Utrecht Inst Pharmaceut Sci, Biomol Mass Spectrometry & Prote Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands.
-
show less...
-
Univ Utrecht, Utrecht Inst Pharmaceut Sci, Biomol Mass Spectrometry & Prote Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands Netherlands Canc Inst, Oncode Inst, Canc Genom Ctr Netherlands, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands. (creator_code:org_t)
- AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, 2018
- 2018
- English.
-
In: Molecular & Cellular Proteomics. - : AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC. - 1535-9476 .- 1535-9484. ; 17:10, s. 1892-1908
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Intrinsic and/or acquired resistance represents one of the great challenges in targeted cancer therapy. A deeper understanding of the molecular biology of cancer has resulted in more efficient strategies, where one or multiple drugs are adopted in novel therapies to tackle resistance. This beneficial effect of using combination treatments has also been observed in colorectal cancer patients harboring the BRAF(V600E) mutation, whereby dual inhibition of BRAF(V600E) and EGFR increases antitumor activity. Notwithstanding this success, it is not clear whether this combination treatment is the only or most effective treatment to block intrinsic resistance to BRAF inhibitors. Here, we investigate molecular responses upon single and multi-target treatments, over time, using BRAF(V600E) mutant colorectal cancer cells as a model system. Through integration of transcriptomic, proteomic and phosphoproteomics data we obtain a comprehensive overview, revealing both known and novel responses. We primarily observe widespread up-regulation of receptor tyrosine kinases and metabolic pathways upon BRAF inhibition. These findings point to mechanisms by which the drug-treated cells switch energy sources and enter a quiescent-like state as a defensive response, while additionally compensating for the MAPK pathway inhibition.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Ressa, Anna
-
Bosdriesz, Evert
-
de Ligt, Joep
-
Mainardi, Sara
-
Maddalo, Gianluc ...
-
Prahallad, Aniru ...
-
show more...
-
Jager, Myrthe
-
de la Fonteijne, ...
-
Fitzpatrick, Mar ...
-
Groten, Stijn
-
Altelaar, A. F. ...
-
Bernards, Rene
-
Cuppen, Edwin
-
Wessels, Lodewyk
-
Heck, Albert J. ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
- Articles in the publication
-
Molecular & Cell ...
- By the university
-
Royal Institute of Technology
-
Karolinska Institutet